Andrew Schiermeier Intellia Therapeutics, Inc. (NTLA) insider trading activity

NTLA Quotes by TradingView

Andrew Schiermeier is EVP, Chief Operating Officer of Intellia Therapeutics, Inc.. Currently has a direct ownership of 16,656 shares of NTLA, which is worth approximately $367,431. The most recent transaction as insider was on Jan 05, 2021, when has been sold 1,377 shares (Common Stock) at a price of $55.86 per share, resulting in proceeds of $76,919. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 16.7K
0% 3M change
0% 12M change
Total Value Held $367,431

ANDREW SCHIERMEIER Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 05 2021
SELL
Open market or private sale
$76,919 $55.86 p/Share
1,377 Reduced 7.64%
16,656 Common Stock
Dec 31 2020
BUY
Exercise of conversion of derivative security
-
4,792 Added 20.99%
18,033 Common Stock
Dec 30 2020
BUY
Exercise of conversion of derivative security
$20,220 $13.48 p/Share
1,500 Added 10.58%
12,673 Common Stock
AS

Andrew Schiermeier

EVP, Chief Operating Officer
Cambridge, MA

Track Institutional and Insider Activities on NTLA

Follow Intellia Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NTLA shares.

Notify only if

Insider Trading

Get notified when an Intellia Therapeutics, Inc. insider buys or sells NTLA shares.

Notify only if

News

Receive news related to Intellia Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NTLA